Inventor

CHEN LIEPING

US53 patents

⚠️ This page may combine multiple inventors who share the name “CHEN LIEPING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CHEN LIEPING

CHEN LIEPING

B7-H1 antibodies and method of use

B7-H1 Antibodies

B7-DC variants immunogenic compositions and methods of use thereof

Methods of modulating immune function

B7-H1, a novel immunoregulatory molecule

B7-DC variants immunogenic compositions and methods of use thereof

Nucleic acid molecules encoding B7-DC variants

Methods for treating inflammation using B7-H4 polypeptides and fragments thereof

Methods for treating autoimmune diseases using B7-H4 polypeptides and fragments thereof

Enhancement of immune responses by 4-1 BB-binding agents

B7-H1 and methods of diagnosis, prognosis, and treatment of cancer

Enhancement of immune responses by 4-1BB-binding agents

B7-H3 and B7-H4, novel immunoregulatory molecules

Compositions and methods for the treatment of immunologic disorders

Antibody specific for B7-H5, a costimulatory polypeptide

Detection and diagnosis of inflammatory disorders

MAYO FOUNDATION

Methods of enhancing T cell responsiveness

T-cell immunoregulatory molecule

B7-H1, a novel immunoregulatory molecule

B7-H1 variants

B7-H1 and methods of diagnosis, prognosis, and treatment of cancer

B7-H5, a costimulatory polypeptide

Enhancement of immune responses by 4-1bb-binding agents

Nucleic acids encoding B7-H4, a T cell immunoregulatory molecule

B7-DC variants

B7-H3 and B7-H4, novel immunoregulatory molecules

Nucleic acids encoding B7-H4, a T cell immunoregulatory molecule

Detection of antibodies specific for B7-H1 in subjects with diseases or pathological conditions mediated by activated T cells

B7-H3 and B7-H4, novel immunoregulatory molecules

Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target

B7-H5, a costimulatory polypeptide

MAYO FOUND MEDICAL EDUCATION & RES

B7-H5, a costimulatory polypeptide

B7-H5, a costimulatory polypeptide

B7-H5, a costimulatory polypeptide

Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target

Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target

TAYU HUAXIA BIOTECH MEDICAL GROUP CO LTD

Compositions and uses thereof for treating disease or condition

Anti-PD-1 antibodies and uses thereof

Anti-PD-1 antibodies and uses thereof

Anti-PD-L1 diabodies and the use thereof

Anti-PD-1 antibodies, dosages and uses thereof

UNIV JOHNS HOPKINS

Compositions and methods for treating inflammation and auto-immune diseases

Detection and diagnosis of inflammatory disorders

Methods of modulating immune function

MEDIMMUNE LLC

Anti-human B7-H4 antibodies and their uses

Anti-B7-H5 antibodies and their uses

BRISTOL MYERS SQUIBB CO

Methods and compositions for immunomodulation

Inhibition of tumor cell growth by administration of B7-transfected cells

SHENZHEN HUAZHI TRADING CO LTD

Weed puller

UNIV YALE

Genome-scale T cell activity array and methods of use thereof